Title |
The Role of Tobacco, Alcohol, and Obesity in Neoplastic Progression to Esophageal Adenocarcinoma: A Prospective Study of Barrett's Esophagus
|
---|---|
Published in |
PLOS ONE, January 2013
|
DOI | 10.1371/journal.pone.0052192 |
Pubmed ID | |
Authors |
Sheetal Hardikar, Lynn Onstad, Patricia L. Blount, Robert D. Odze, Brian J. Reid, Thomas L. Vaughan |
Abstract |
Esophageal adenocarcinoma (EA) incidence in many developed countries has increased dramatically over four decades, while survival remains poor. Persons with Barrett's esophagus (BE), who experience substantially elevated EA risk, are typically followed in surveillance involving periodic endoscopy with biopsies, although few progress to EA. No medical, surgical or lifestyle interventions have been proven to safely lower EA risk. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Malaysia | 1 | 1% |
United States | 1 | 1% |
Ecuador | 1 | 1% |
Egypt | 1 | 1% |
Unknown | 81 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 16 | 19% |
Researcher | 13 | 15% |
Student > Doctoral Student | 8 | 9% |
Student > Master | 5 | 6% |
Student > Ph. D. Student | 5 | 6% |
Other | 15 | 18% |
Unknown | 23 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 38 | 45% |
Biochemistry, Genetics and Molecular Biology | 5 | 6% |
Agricultural and Biological Sciences | 4 | 5% |
Nursing and Health Professions | 2 | 2% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
Other | 6 | 7% |
Unknown | 28 | 33% |